Nav: Home

Current Placebo News and Events

Current Placebo News and Events, Placebo News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Drug reverses signs of liver disease in people living with HIV
Researchers at the National Institutes of Health and their colleagues at Massachusetts General Hospital (MGH) in Boston report that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV. (2019-10-11)
Researchers identify potential therapy for liver disease in people living with HIV
Researchers have identified a novel therapeutic strategy to significantly improve liver disease in people living with HIV. (2019-10-11)
Melatonin may not help prevent delirium after heart surgery
Delirium is observed in approximately 15% of hospitalised older adults, and it is more common in the critically ill and in those undergoing major surgery, such as heart surgery. (2019-10-09)
Dietary supplement from tomatoes discovered to boost sperm quality
Sperm quality can be improved with a simple diet supplement containing a compound found in cooked tomatoes, according to new research by the University of Sheffield. (2019-10-09)
Experimental growth factor shows promise for treating knee osteoarthritis
A new experimental growth factor therapy appears to prevent a worsening of osteoarthritis by increasing the thickness of cartilage in the knee joint and preventing further loss, according to results from an early clinical trial that were published today in the Journal of the American Medical Association. (2019-10-08)
Did IV high-dose vitamin C improve outcomes for patients with sepsis and severe lung condition?
This randomized clinical trial looked at whether high-dose vitamin C delivered intravenously could reduce organ failure, inflammation and vascular injury in patients with sepsis and acute respiratory distress syndrome (ARDS), a severe lung condition that is a common organ injury associated with sepsis. (2019-10-01)
Treatment with long term, low dose antibiotic could help people born with chronic lung condition
Taking a low dose of the antibiotic azithromycin for 6 months reduces symptoms for patients with the chronic lung condition primary ciliary dyskinesia (PCD), according to research presented at the European Respiratory Society International Congress. (2019-10-01)
In major meta-analysis, omega-3 fish oil supplements linked with lower cardiovasc
People who received omega-3 fish oil supplements in randomized clinical trials had lower risks of heart attack and other cardiovascular disease (CVD) events compared with those who were given placebo (2019-09-30)
Nintedanib slows progression for broad range of scarring lung diseases
Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases. (2019-09-29)
Poorly reported placebos could lead to mistaken estimates of benefits and harms
Researchers at the University of Oxford have found that placebo controls are almost never described according to standard reporting guidelines. (2019-09-29)
PARP inhibitor plus chemotherapy improves progression-free survival for advanced ovarian cancer patients
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival (PFS) for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial. (2019-09-28)
PACIFIC survival explained: Cancer spread reduced, new distant growth most often in the brain
A new analysis of survival data for the randomized, phase III PACIFIC trial finds adding the immunotherapy cancer drug durvalumab to radiation and chemotherapy significantly decreased the recurrence of lung cancer both in the chest area and in distant sites outside the chest. (2019-09-26)
New research shows dapagliflozin used to treat diabetes can also
Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D. (2019-09-19)
Study shows both natural variation in ACE concentrations and lowering blood pressure with ACE inhibitors are associated with lower risk of type 2 diabetes
New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (Sept. (2019-09-19)
Few people with peanut allergy tolerate peanut after stopping oral immunotherapy
Studies have shown that peanut oral immunotherapy (OIT) -- ingesting small, controlled amounts of peanut protein -- can desensitize adults and children and prevent allergic reactions, but the optimal duration and dose is unknown. (2019-09-12)
Keynote 189: Tumor mutational burden not significantly associated with efficacy of pembrolizumab
Tumor mutational burden was not significantly associated with efficacy of pembrolizumab plus chemotherapy or placebo plus chemotherapy as first-line therapy for metastatic nonsquamous non-small cell lung cancer, according to research reported today by Dr. (2019-09-08)
Study shows BioCell collagen can visibly reduce common signs of skin aging within 12 weeks
In one of the most substantial studies of a skin health supplement, BioCell Collagen®, was found to visibly reduce common signs of skin aging, including lines and wrinkles, within 12 weeks of daily use. (2019-09-04)
Mouthwash use could inhibit benefits of exercise, new research shows
An international team of scientists has shown that the blood pressure-lowering effect of exercise is significantly reduced when people rinse their mouths with antibacterial mouthwash, rather than water - showing the importance of oral bacteria in cardiovascular health. (2019-09-03)
For patients with diabetes, ticagrelor reduced heart attacks, strokes
In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals -- AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study (THEMIS). (2019-09-01)
Promising clinical trial results for drug for rare disease in which patients can't eat fat
In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could also help inform better prevention methods and treatments for many types of heart disease. (2019-08-08)
Psychotherapy should be first-line treatment for depression in young people, trial finds
Young people seeking support for depression should be offered psychotherapy as the first line of treatment, a clinical trial by researchers at Orygen, the National Centre of Excellence in Youth Mental Health, has found. (2019-07-31)
Tart cherry juice may juice up the brain
In a new study published in Food & Function , researchers at the University of Delaware found daily intake of Montmorency tart cherry juice improved memory scores among adults, ages 65 to 73 years. (2019-07-28)
Novel rheumatoid arthritis drug succeeds in clinical trial led by Stanford investigator
Rheumatoid arthritis patients getting little or no relief from conventional small-molecule drugs and injectable biologic drugs saw substantial improvement in their condition from daily use of an experimental compound in a large 24-week study led by a Stanford University School of Medicine investigator. (2019-07-23)
Shingles vaccine safely prevents outbreaks among stem cell transplant patients
A newer form of shingles vaccine reduced outbreaks of the painful rash among patients who were transplanted with their own stem cells, according to a study led by a Duke Health researcher and published today in JAMA. (2019-07-10)
New shingles vaccine reduced occurrence in patients who had stem cell transplantation
The new, nonlive shingles vaccine reduced the occurrence of shingles (herpes zoster) compared with placebo among patients who had undergone stem cell transplantation with their own stem cells. (2019-07-09)
Heart attack patients with diabetes may benefit from cholesterol-lowering injections
Regular injections of a cholesterol-cutting drug could reduce the risk of heart attack or stroke in patients with diabetes and who have had a recent heart attack. (2019-07-01)
Hypertension drug may hold promise for Alzheimer's disease
The blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center, without affecting other brain regions among people with Alzheimer's disease. (2019-06-17)
Tildrakizumab shows promising efficacy and safety in psoriatic arthritis
The results of a phase 2B study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate superior efficacy and comparable safety of tildrakizumab versus placebo in patients with psoriatic arthritis. (2019-06-14)
Linagliptin improved albuminuria but effect on eGFR and CV risk in patients with diabetes
In the CARMELINA trial nearly 10% of all patients with diabetes had nephrotic-range proteinuria at baseline. (2019-06-14)
Tart cherry shown to decrease joint pain, sore muscles in some breast cancer patients
Tart cherry reduces the musculoskeletal effects of aromatase inhibitors in patients with non-metastatic breast cancer, according to new findings from a clinical trial by researchers at Marshall University Joan C. (2019-06-10)
Large international study finds diabetes drug cuts cardiovascular and kidney problems
A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with type 2 diabetes. (2019-06-09)
The Lancet journals: Papers at American Diabetes Association (ADA) 2019
The following papers will be presented at the ADA conference in San Francisco and published simultaneously in either The Lancet or The Lancet Diabetes & Endocrinology journals. (2019-06-09)
Three-drug combination helps curb the growth of deadly type of skin cancer
A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma. (2019-06-06)
Alzheimer's therapy may help overcome opioid addiction
Clinical trial results reveal that a medication used to treat Alzheimer's disease may also be an effective therapy for individuals addicted to opioids. (2019-06-05)
POLO trial for advanced pancreatic cancer: a new standard of care
Treatment with the drug olaparib significantly reduced the risk of disease progression or death from metastatic pancreatic cancer, according to findings from the recently completed, international, phase-III POLO (Pancreas cancer OLaparib Ongoing) trial. (2019-06-03)
Vitamin D could help cancer patients live longer
Michigan State University physicians have found that vitamin D, if taken for at least three years, could help cancer patients live longer. (2019-06-03)
Ribociclib plus hormone therapy extends survival for patients with premenopausal advanced hormone receptor-positive breast cancer
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center. (2019-06-01)
Energy drinks may increase risk of heart function abnormalities and blood pressure changes
Three to four hours after drinking 32 ounces of energy drinks, the heart's electrical activity was abnormal compared to drinking a placebo drink. (2019-05-29)
Short-term use of opioids increases subjective pleasure
As indicated by a recently published study, short-term opioid use shifts a range of emotional responses to the positive direction. (2019-05-24)
CBD clinical trial results on seizure frequency in dogs 'encouraging'
Dr. Stephanie McGrath found in a small study that 89 percent of dogs who received CBD in the clinical trial had a reduction in the frequency of seizures. (2019-05-21)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...